Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06460038
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-14
First Post:
2024-06-11
Brief Title:
Tenapanor in Synucleinopathy-Related Constipation
Sponsor:
Cedar Valley Digestive Health Center
Organization:
Cedar Valley Digestive Health Center
Study Overview
Official Title:
Efficacy and Safety of Tenapanor in Synucleinopathy-Related Constipation
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Investigation of tenapanor as a potential treatment for synucleinopathy-associated constipation
Detailed Description:
Randomized double-blind placebo controlled trial of tenapanor vs placebo for treating synucleinopathy-associated constipation in Parkinson39s disease
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None